For over 25 years, Jeff Hurlburt has advised investors, including private equity (PE) and venture capital (VC) investors; corporate clients; and investment banks active in a variety of industry sectors. Many of his clients are in the technology, media, and telecom; and life sciences industries.

Since starting his practice in New York City in 1988, and moving to London to practice in 1997, Jeff has continued to focus on a variety of international financial transactions. Jeff's deal experience includes effectively negotiating and closing a multitude of cross-border mergers and acquisitions (M&A), international private equity and venture capital transaction (both on behalf of companies and investors), U.S. and international private placements and public offerings including Rule 144A, Regulation S and dual-listed offerings.

Jeff also is actively involved in our international fund formation practice and is a key member of our Scandinavian-focused client group, having represented a number of Norwegian, Swedish, and other Nordic clients over the years.

Awards and recognitions


M&A/Corporate and Commercial: Venture Capital and Emerging Companies
Legal 500 US


Investment Fund Formation and Management: Private Equity Funds
Legal 500 US

2007, 2011-2014

Mergers, Acquisitions, and Buyouts: Private Equity Buyouts
Legal 500 US


M&A: US Capability
The Legal 500 UK Edition


Chambers UK, Private Equity: Buyouts


Venture Capital
The Legal 500 UK Edition


UK Legal Expert, Corporate/M&A
Legal Business


Acquisitions Monthly, "Nordic M&A Adviser of the Year Award" Team Leader

Education and admissions


J.D., The University of Iowa College of Law, with honors, 1988

B.A., The University of Iowa, 1985

A.A., Mount St. Clare College, 1983


Registered Foreign Lawyer, The Law Society of England and Wales

Bar admissions and qualifications

New York

District of Columbia

Representative experience

Advising UK-based Supponor Ltd., in a variety of general corporate, investment, and restructuring transactions.

Representing Northzone Ventures in the formation of their TMT-focused venture capital funds and a variety of their international transactions.

Representation of the underwriters of a EUR$2.9bn initial public offering of a European Internet and telecommunications services provider.

Representing the International Finance Corporation on a variety of equity-related investments and transaction matters.

Represented Pronova Biopharma in its NOK 2.7bn IPO on the Oslo Stock Exchange, including a Rule 144A private placement into the United States.

Advising a syndicate of VC and other selling shareholders in connection with the US$85m sale of Arieso, Ltd., to U.S. publicly traded JDSU.

Advising a syndicate of European VC investors in the US$123m sale of Alphamosaic Limited to U.S. publicly traded Broadcom, Inc.

Advised Herkules Capital et al on EUR$662.9m acquisition of Nordic oil & gas service company from a syndicate of UK and European PE investors.

Loading data